Home News & Updates

News & Updates

ACT-AD Letter on FDA Early Alzheimer’s Disease Guidance

  Update   June 15, 2018   FDA

Researchers Reverse Alzheimer’s Disease in Mouse Models

  Update   February 10, 2018   Uncategorized

Experimental Drug Could Be Viable Treatment for Alzheimer’s Disease

  Update   January 19, 2018   Uncategorized

Canola Oil May Play a Role in Worsening of Alzheimer’s Disease Symptoms

  Update   December 28, 2017   Uncategorized

Recent NIH Forecast Highlights Number of People Living with Alzheimer’s Disease

  Update   December 22, 2017   Uncategorized

Audio Conference to Discuss the ACT-AD-Sponsored Study

  Update   November 21, 2017   Uncategorized

An Update on the CTAD Conference

  Update   November 7, 2017   Event Recap

Alzheimer’s Association International Conference Recap

  Update   August 10, 2017   Event Recap

ACT-AD Urges Congress to Provide FDA with $2.8B in FY 2018

  Update   March 7, 2017   Uncategorized

ACT-AD Executive Director Joins Panel on FDA and Patient Centeredness

  Update   January 12, 2017   FDA